Related Experiment Video
Updated: Nov 25, 2025

Detection of Anti-MDA5 Autoantibodies Using HeLa Cells and Immunocytochemistry with Light Microscopy
Published on: October 31, 2025
Management strategies for dermatomyositis during the coronavirus disease 2019 outbreak
Zixin Pi1, Pan Chen1, Yi Zhan1
1Department of Dermatology, The Second Xiangya Hospital of Central South University, Changsha, China.
Abstract:
In late 2019, the coronavirus disease 2019 (COVID-19) broke out in Wuhan and then spread over China, which greatly affected the medical practices and health care systems. With most of the hospital's outpatient services closed, the routine clinical diagnosis and treatment for patients with dermatomyositis has been disturbed. We conducted telephone follow-up for 52 patients to know the changes in the condition and the continuation of drug therapy and to ensure the continuity, safety, and effectiveness of the treatment of patients with dermatomyositis during COVID-19.
Related Concept Videos
Myocarditis III: Medical Management
Myocarditis IV: Nursing Management
Pericarditis III: Medical Management
Rheumatic Heart Disease III: Medical Management
Drugs Used in Lower Respiratory Disorders: Overview
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
Endocarditis III: Medical Management

